Publication | Closed Access

Ipragliflozin, an SGLT2 inhibitor, exhibits a prophylactic effect on hepatic steatosis and fibrosis induced by choline-deficient l-amino acid-defined diet in rats

InflammationMetabolic SyndromeSglt2 InhibitorHepatologyMedicineLiver PhysiologyPathologyHepatotoxicityLiver DiseaseHepatic SteatosisHepatology FibrosisMetabolomicsFatty Liver DiseasePharmacologyDrug-induced Liver InjuryProphylactic EffectOxidative StressHealth Sciences